Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...

The death of a boy with Duchenne muscular dystrophy, tied to a gene therapy, is above all a tragedy. But it is also ...

During a talk at the recent Jefferies Global Healthcare Conference, Cogent CEO Andy Robbins said Blueprint Medicines’ Ayvakit ...

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care ...

New brain-computer interface reduced time lag in translating thoughts into speech in a meaningful advance for the field.

Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else.

Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...

A U.K. health agency said the Alzheimer's drugs Kisunla and Leqembi are not cost-effective, meaning they won't be offered through the NHS.

The latest from the BIO 2025 conference: more universities open to private equity deals, emerging companies turn to new ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.